正高级工程师。2008年获中国科学院生态环境研究中心博士学位,同年进入中国科学院上海生命科学研究院进行博士后研究,2011年进入中国科学院上海高等研究院工作,历任副研究员和研究员。承担国家重点研发计划、国家自然科学基金、中国科学院STS区域重点及企业横向项目30多项。在Journal of Bioresources and Bioproducts、Microbial Cell Factories、Applied and Environmental Microbiology等期刊发表SCI论文45篇,申请和授权发明专利26项。目前兼任微生物菌种筛选与应用国家地方联合工程研究中心学术委员,《Sustainability》编委。
1. 微生物代谢工程与合成生物学
2. 新型甾体药物绿色生物合成
1. 上海市浦东明珠人才
2. 赛诺菲·安万特-中国科学院上海生命科学研究院优秀青年人才奖励基金
1. 国家重点研发项目,“长三角地区主要病虫害RNA 农药靶序列高效筛选、生物合成及高效组装机制的研究”,子课题负责人,2024.12-2029.12;
2. 福建省中国科学院STS重大项目,“生物法高效制备食品级L-酪氨酸产业化技术研究与应用”,课题负责人,2022.03-2026.3;
3. 国家重点研发计划,“农业生产副产物和废弃物高值化利用生物技术开发”,项目负责人,2018.07-2021.06;
4. 国家重点研发计划,“农业废弃物资源化利用机制”,子课负责人, 2017.01-2021.06;
5. 地方科技攻关,“微生物定向转化植物甾醇制备新型甾药中间体”,项目负责人,2023.01-2025.06;
6. 地方横向,“假丝酵母细胞构建与优化 ” ,项目负责人,2025.04-2029.04;
7. 地方横向,“生物催化法合成羟基类固醇类关键医药中间体研究 ” ,项目负责人,2024.05-2029.04; 8. 地方横向,“生物催化法合成 L-肌肽工艺开发” ,项目负责人,2022.11-2028.10。
1.论文:
[1] Metabolic engineering of Mycobacterium fortuitum for high-level production of sitolactone from biorenewable phytosterols. Process Biochemistry. 2025,153 ,30-23[7] (通讯作者)
[2] Efficient production of 9α-hydroxy-steroid from phytosterols in mycobacterium fortuitum ATCC 6842 by modifying multiple genes. Biochemical Engineering Journal. 2025, 218, 10968[9] (通讯作者)
[3] Valorization of the Caragana Waste via Two-Stage Bioaugmentation Optimizing Nutrition Composition, Palatability, and Microbial Contaminant. Journal of Bioresources and Bioproducts, 2024,9:518–533 ; (通讯作者)
[4] Functional characterization of two reductase KshBs in Mycobacterium fortuitum and their applications to C9 non-hydroxylated steroid production. Process Biochemistry, 2024,144,256-265; (通讯作者)
[5] XPhytosterol Conversion into C9 Non-hydroxylated Derivatives through Gene Regulation in Mycobacterium fortuitum. Applied Microbiology and Biotechnology, 202[3] [10] 13; (通讯作者)
[6] Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ1 -dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum. Microbial Cell Factories,2023,22(53);(通讯作者)
[7] Functional analysis of acyl-CoA dehydrogenases and their application to C22 steroid production. Applied Microbiology and Biotechnology. 2023,107:3419–3428; (通讯作者)
[8] Bioconversion of Phytosterols to 9-Hydroxy-3-Oxo-4,17-Pregadiene-20-Carboxylic Acid Methyl Ester by Enoyl-CoA Deficiency and Modifying Multiple Genes in Mycolicibacterium neoaurum. Applied and Environmental Microbiology,2022,88(22):e0130322); (通讯作者)
[9] Production of 9,21-dihydroxy-20-methyl-pregna-4-en-3-one from phytosterols in Mycobacterium neoaurum by modifying multiple genes and improving the intracellular environment. Microbial Cell Factories, 2021,12,6;(通讯作者)
[10] Purification, characterization, and application of a high activity 3-ketosteroid-Δ1-dehydrogenase from Mycobacterium neoaurum DSM 138[1] Applied Microbiology and Biotechnology,2019, DOI: [10] 1007/s00253-019-09988-5; (通讯作者)
2.代表性专利
[1] 张保国;翟星荟等;一种用于生产制备谷内酯的基因工程菌及其制备方法和应用,专利申请号:2025101175529
[2] 张保国; 刘相岑等; 一种用于生产制备9-OHAD的基因工程菌株、及其制备方法和应用, 专利授权号:ZL2023100395556
[3] 张保国;袁辰阳等;一种产甾药前体的基因工程菌及其用途,专利授权号:ZL202210730036X;
[4] 张保国;刘相岑等;一种产双降醇的基因工程菌及其用途,专利授权号: 2022107293262; [5] 张保国等;甘油脱氢酶突变体、产二羟基丙酮的重组菌及其用途,授权专利号:ZL202210892893X。